[Hormone treatment of breast cancer in the advanced phase].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005474:Fluoxymesterone / Q000627:therapeutic use*; D006062:Gonadotropins / Q000378:metabolism; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D009277:Nandrolone / Q000627:therapeutic use*; D010616:Phenanthrenes / Q000627:therapeutic use*; D012632:Secosteroids / Q000627:therapeutic use; D013738:Testolactone / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006062:Gonadotropins; D007783:Lactones; D010616:Phenanthrenes; D012632:Secosteroids; D013739:Testosterone; D013738:Testolactone; D009277:Nandrolone; D005474:Fluoxymesterone
Traitement hormonal du cancer du sein en phase avancée.